Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ...

ImmunityBio, Inc. , a leading immunotherapy company, today announced significant progress in its ongoing discussions with the U.S. Food and Drug Administration (FDA) regarding three areas of its ...

Subcutaneous Opdivo improves cancer care by offering faster, accessible therapy, reducing time toxicity and expanding patient ...

Anixa Biosciences CEO Amit Kumar discusses the biotech’s plans for advancing a breast cancer vaccine in 2025. The cancer ...

Cigarette smoking is widespread and deadly, yet our understanding of how cigarette smoke actually causes serious respiratory ...

Immunotherapy is a modern approach to cancer treatment that uses a patient’s own immune system to help fight tumors. It has ...

OS Therapies (OSTX) up 65% in premarket trading after positive phase 2b data on OST-HER2 for lung metastatic osteosarcoma ...

A loss-of-function mutation to the PTPN2 gene, commonly associated with autoimmune diseases, can make cells more susceptible to SARS-CoV-2 infection.

Small Cell Lung Cancer Pipeline Insight 2025' report provides comprehensive global coverage of pipeline NSCLC therapies in ...

Researchers have identified a novel genetic risk factor for SARS-CoV-2 infection, providing new insights into the virus' ability ...

How can we ensure that life-saving drugs or genetic therapies reach their intended target cells without causing harmful side ...